Milk fermented by Lactobacillus casei CRL431 modifies cytokine profiles associated to different stages of breast cancer development in mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Milk fermented by Lactobacillus casei CRL431 modifies cytokine profiles associated to different stages of breast cancer development in mice
Authors
Keywords
-
Journal
Beneficial Microbes
Volume -, Issue -, Pages 1-10
Publisher
Wageningen Academic Publishers
Online
2019-05-24
DOI
10.3920/bm2019.0011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral administration of milk fermented by Lactobacillus casei CRL431 was able to decrease metastasis from breast cancer in a murine model by modulating immune response locally in the lungs
- (2019) Virginia Emilce Mendez Utz et al. Journal of Functional Foods
- Validating the pivotal role of the immune system in low-dose radiation-induced tumor inhibition in Lewis lung cancer-bearing mice
- (2018) Lei Zhou et al. Cancer Medicine
- Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities
- (2017) Junko Masuda et al. ONCOLOGY REPORTS
- IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
- (2017) Kazuyoshi Takeda et al. Nature Communications
- Interactions between the tumor and the blood systemic response of breast cancer patients
- (2017) Vanessa Dumeaux et al. PLoS Computational Biology
- Inhibition of Growth and Metastasis of Breast Cancer in Mice by Milk Fermented With Lactobacillus casei CRL 431
- (2015) Félix Aragón et al. JOURNAL OF IMMUNOTHERAPY
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- Tumor cell secretion of soluble factor(s) for specific immunosuppression
- (2015) Arihiro Kano Scientific Reports
- The administration of milk fermented by the probiotic Lactobacillus casei CRL 431 exerts an immunomodulatory effect against a breast tumour in a mouse model
- (2014) Félix Aragón et al. IMMUNOBIOLOGY
- Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy
- (2013) Matthew D. Vesely et al. Annals of the New York Academy of Sciences
- The role of intratumoral and systemic IL-6 in breast cancer
- (2013) Christine Dethlefsen et al. BREAST CANCER RESEARCH AND TREATMENT
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes
- (2013) Zahra Faghih et al. IMMUNOLOGY LETTERS
- Cytokine patterns in patients with cancer: a systematic review
- (2013) Bodo E Lippitz LANCET ONCOLOGY
- T-helper-1-cell cytokines drive cancer into senescence
- (2013) Heidi Braumüller et al. NATURE
- The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology
- (2012) L. Bertazza et al. CURRENT MEDICINAL CHEMISTRY
- Role of interleukin-10 in breast cancer
- (2011) Hamidullah et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent models
- (2007) Shih-Houng Young et al. JOURNAL OF IMMUNOLOGICAL METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started